-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A60WJs3EFK+1MZ8bcsQ0AyCnKrYQjtPbpk5TobKu0mDTc9s90fiNrcHnRWjY7GMI w5m7GFy3ueifDsi9KQ/gPg== 0000912057-00-004621.txt : 20000210 0000912057-00-004621.hdr.sgml : 20000210 ACCESSION NUMBER: 0000912057-00-004621 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-94161 FILM NUMBER: 528012 BUSINESS ADDRESS: STREET 1: 150 INDUSTRIAL RD. CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6506313100 MAIL ADDRESS: STREET 1: 150 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 424B3 1 424B3 FILED PURSUANT TO RULE 424(b)(3) AND (c) FILE NUMBER 333-94161 PROSPECTUS SUPPLEMENT NO. 1 DATED FEBRUARY 8, 2000 TO PROSPECTUS DATED JANUARY 26, 2000 INHALE THERAPEUTIC SYSTEMS, INC. $108,450,000 OF 6 3/4% CONVERTIBLE SUBORDINATED DEBENTURES DUE OCTOBER 13, 2006 AND 3,388,268 SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THE DEBENTURES This prospectus supplement supplements the prospectus dated January 26, 2000 of Inhale Therapeutic Systems, Inc. relating to the offering and sale by selling security holders described below. This prospectus supplement contains information on ownership of principal amount of debentures beneficially owned and offered and shares of our common stock issuable upon conversion of the debentures. This prospectus supplement should be read in conjunction with the prospectus, and this prospectus supplement is qualified by reference to the prospectus, except to the extent that the information provided by this prospectus supplement supersedes the information contained in the prospectus. SELLING SECURITY HOLDERS The table on pages 57, 58, 59 and 60 of the prospectus setting forth information concerning the selling security holders is amended by the addition of the following information to that table:
PRINCIPAL AMOUNT OF COMMON STOCK COMMON STOCK DEBENTURES ISSUABLE UPON OWNED AFTER BENEFICIALLY OWNED CONVERSION OF THE COMMON STOCK COMPLETION OF THE SELLING SECURITY HOLDER AND OFFERED (1) DEBENTURES OFFERED OFFERING Deephaven Domestic Convertible Trading Ltd...................... $ 1,000,000 31,242 31,242 -- Merrill Lynch, Pierce, Fenner & Smith, Inc. (2).................. $ 10,250,000 320,237 320,237 -- Rumson Capital LLC, as Investment Advisor f/b/o Navesink Equity Derivative Fund.................. $ 3,000,000 93,728 93,728 -- AAM/Zazove Institutional Income Fund, L.P........................ $ 400,000 12,497 12,497 -- San Diego County Employees Retirement Association........... $ 1,000,000 31,242 31,242 -- ZCM/HFR Index Management, LLC...... $ 100,000 3,124 3,124 --
(1) Amounts indicated may be in excess of the total amount registered due to sales or transfers exempt from the registration requirements of the Securities Act since the date upon which the selling holders provided to us in the information regarding their debentures. (2) Merrill Lynch, Pierce, Fenner & Smith, Inc. acted as Conversion Manager in connection with privately negotiated agreements with certain holders of the Company's debentures, providing for the conversion of approximately $94.2 million aggregate principal amount of the debentures in exchange for cash payments of approximately $16.2 million in the aggregate. It also served as a Joint Lead Manager and an initial purchaser in the sale of $200 million aggregate principal amount of the Company's 5% Convertible Subordinated Notes due 2007 in February 2000 ($230 million if the over-allotment option is exercised in full). Information concerning the selling holders may change from time to time and any changed information will be set forth in supplements to this prospectus if and when necessary. In addition, the conversion rate and therefore, the number of shares of common stock issuable upon conversion of the debentures, is subject to adjustment under certain circumstances. Accordingly, the aggregate principal amount of debentures and the number of shares of common stock into which the debentures are convertible may increase or decrease.
-----END PRIVACY-ENHANCED MESSAGE-----